Chemistry and Bifunctional Chelating Agents for Binding Lu-177

被引:16
|
作者
Parus, Jozef L. [1 ]
Pawlak, Dariusz [1 ]
Mikolajczak, Renata [1 ]
Duatti, Adriano [2 ]
机构
[1] Natl Ctr Nucl Res, Radioisotope Ctr POLATOM, PL-05400 Otwock, Poland
[2] Univ Ferrara, Nucl Med Lab, I-44121 Ferrara, Italy
关键词
Bifunctional chelators; chemistry of lutetium; DOTA; DTPA; lanthanides; Lutetium; lutetium-177; radiopharmaceuticals; NOTA;
D O I
10.2174/1874471008666150312160440
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
A short overview of fundamental chemistry of lutetium and of structural characteristics of lutetium coordination complexes, as relevant for understanding the properties of lutetium-177 radio-pharmaceuticals, is presented. This includes basic concepts on lutetium electronic structure, lanthanide contraction, coordination geometries, behavior in aqueous solution and thermodynamic stability. An illustration of the structure and binding properties of the most important chelating agents for the Lu3+ ion in aqueous solution is also reported with specific focus on coordination complexes formed with linear and macrocyclic polydentate amino-carboxylate donor ligands.
引用
收藏
页码:86 / 94
页数:9
相关论文
共 50 条
  • [1] Patient release after Lu-177 DOTATATE and Lu-177 PSMA 617 therapies
    Mair, C.
    Warwitz, B.
    Buxbaum, S.
    Virgolini, I. J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S454 - S454
  • [2] MEASURING LU-177M CONTAMINATION IN LU-177
    Badger, D.
    INTERNAL MEDICINE JOURNAL, 2015, 45 : 12 - 13
  • [3] RADIATIONS FROM LU-177
    DOUGLAS, DG
    PHYSICAL REVIEW, 1949, 75 (12): : 1960 - 1961
  • [4] EXCITATION OF BANDS IN LU-177
    MANFRASS, P
    ANDREJTSCHEFF, W
    NUCLEAR PHYSICS A, 1972, A194 (03) : 561 - +
  • [5] Effect of Number of Bifunctional Chelating Agents on the Pharmacokinetics and Immunoreactivity of 177Lu-labeled Rituximab: A Systemic Study
    Guleria, Mohini
    Das, Tapas
    Kumar, Chandan
    Sharma, Rohit
    Amirdhanayagam, Jeyachitra
    Sarma, Haladhar D.
    Dash, Ashutosh
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2018, 18 (01) : 146 - 153
  • [6] MEASUREMENTS CONCERNING DECAY OF LU-177
    FLECK, CM
    NIEDERST.W
    ATOMKERNENERGIE, 1970, 15 (04): : 269 - &
  • [7] QUANTITATIVE RECONSTRUCTION OF LU-177 TOMOGRAPHY
    McKay, E.
    INTERNAL MEDICINE JOURNAL, 2012, 42 : 4 - 4
  • [8] INTENSITY OF LU-177 ELECTRON CONVERSIONS
    KARTASHO.VM
    TROITSKA.AG
    SHEVELEV, GA
    IZVESTIYA AKADEMII NAUK SSSR SERIYA FIZICHESKAYA, 1970, 34 (05): : 1145 - &
  • [9] THE DECAY OF 155 D LU-177
    KRISTENSEN, L
    JORGENSEN, M
    NIELSEN, OB
    SIDENIUS, G
    PHYSICS LETTERS, 1964, 8 (01): : 57 - 60
  • [10] Dosimetry using Lu-177 DOTATATE, Lu-177 HA-DOTATATE and Lu-177 DOTATOC: Comparative Results in Patients Undergoing Peptide Receptor Radionuclide Therapy (PRRT)
    Schuchardt, C.
    Kulkarni, H. R.
    Wiessalla, S.
    Shahinfar, M.
    Shafaei, S.
    Kropf, S.
    Wester, H. J.
    Baum, R. P.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 : S224 - S225